SINGAPORE — (BUSINESS WIRE) — Prestige BioPharma Limited (950210: KRX), a Singapore-based biopharmaceutical with operations in USA and South Korea, announced that the preclinical data of t…
Preclinical Data of Prestige Biopharma』s First-in-Class Pancreatic Cancer Treatment, PBP1510, Presented in ESMO TAT 2022
SINGAPORE — (BUSINESS WIRE) — Prestige BioPharma Limited (950210: KRX), a Singapore-based biopharmaceutical with operations in USA and South Korea, announced that the preclinical data of t…